Lomitapide Capsules (Juxtapid) are an oral microsomal triglyceride transfer protein (MTP) inhibitor indicated for the treatment of homozygous familial hypercholesterolemia (HoFH). Due to the drug’s specific risk management requirements, strict regulations must be followed for its purchase and use.
How to Purchase Lomitapide Capsules (Juxtapid)
1. Overseas Purchase
(1) Patients may choose to consult and purchase lomitapide at hospital pharmacies or licensed retail pharmacies in countries or regions where the drug has been launched.(2) Since drug prices may be affected by factors such as regional differences and exchange rate fluctuations, patients need to make a budget and plan in advance before purchasing.
2. Purchase through Medical Service Institutions
(1) Patients may consult domestic overseas medical service institutions that cooperate with international pharmacies or pharmaceutical companies.
(2) These institutions usually provide legal import channels and can offer professional consultation and guidance.
Precautions for Purchasing Lomitapide Capsules (Juxtapid)
1. Essential Requirements Before Medication Use
(1) Diagnosis Requirement: Genetic testing is required to confirm the diagnosis of homozygous familial hypercholesterolemia (HoFH).
(2) Liver Function Test: Assessment of liver function status is mandatory before initiating medication.
(3) Dietary Control: A very low-fat diet (fat provides < 20% of daily caloric intake) must be followed concurrently.
2. Restrictions for High-Risk Populations
(1) Abnormal Liver Function: Contraindicated in patients with active liver disease or persistent elevations of alanine transaminase (ALT)/aspartate transaminase (AST).
(2) Pregnancy Contraindication: The drug carries a teratogenic risk; effective contraceptive measures must be used during treatment.
(3) Drug Interactions: Concomitant use with moderate to strong CYP3A4 inhibitors is prohibited.
3. Monitoring Requirements
(1) First 12 Months: Monitor ALT/AST levels monthly.
(2) Regular Examinations: Evaluate liver function every 3–6 months.
(3) Lifelong Monitoring: Continuous monitoring of liver health is required even after discontinuing the drug.
How to Identify the Authenticity of Lomitapide Capsules (Juxtapid)
1. Packaging Feature Verification
(1) REMS Logo: Authentic packaging must bear the dedicated logo for the Juxtapid REMS (Risk Evaluation and Mitigation Strategy) program.
(2) Manufacturing Information: Clearly display the manufacturer information "Amryt Pharmaceuticals" and the FDA approval number.
(3) Dosage Form Characteristics: Capsule dosage form, available in strengths of 5 mg, 10 mg, and 20 mg.
2. Channel Verification Methods
(1) REMS Verification: Verify the qualification of the prescribing pharmacy through the official Juxtapid REMS website.
(2) Prescription Tracing: The Prior Authorization Form (PAF) from formal channels must have a complete and traceable serial number.
